PMID: 2113207Jul 1, 1990Paper

Effectiveness of sodium valproate in the treatment of Sydenham's chorea

Neurology
A S DaoudQ al-Saleh

Abstract

We treated 15 children with Sydenham's chorea with sodium valproate at a dose of 15 to 20 mg/kg/d. In 13 of them the chorieform movements disappeared within 1 week of therapy. The remaining 2 had incomplete response. Two patients relapsed; 1 of them responded to the reintroduction of valproate. The mean duration of treatment was 6.7 weeks. We observed no major side effects. This study strongly suggests that valproate is an effective drug in the treatment of Sydenham's chorea.

Citations

Apr 15, 2000·Journal of Clinical Apheresis·R Weinstein
Sep 1, 1995·Annals of Neurology·R C Duvoisin, L I Golbe
Jul 1, 1993·Movement Disorders : Official Journal of the Movement Disorder Society·S GoldmanA Luxen
Jan 1, 1994·Movement Disorders : Official Journal of the Movement Disorder Society·R P Chand, D M Park
Apr 10, 2013·Current Infectious Disease Reports·Judith Barash
Jun 7, 2003·Current Treatment Options in Neurology·Lori C. Jordan, Harvey S. Singer
May 11, 2010·Indian Journal of Pediatrics·Tapas K Sabui, Pragya Pant
Jun 26, 2013·Acta neurologica Belgica·Hicham El OtmaniIlham Slassi
Jul 1, 1995·Schizophrenia Research·M F CasanovaM Kruesi
Aug 11, 2004·International Journal of Cardiology·Vedat DavutogluYusuf Sezen
Oct 6, 2000·Pediatric Neurology·L HarelJ Amir
Jun 21, 2005·Clinical Neuropharmacology·Erika Driver-Dunckley, Virgilio Gerald H Evidente
May 18, 2011·Current Opinion in Neurology·Jessica Panzer, Josep Dalmau
Jul 16, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Sheila Srinivasan, Au Wing Lok
May 18, 2016·Nature Reviews. Disease Primers·Jonathan R CarapetisLiesl Zühlke
Aug 5, 2010·Pediatric Neurology·Daniëlla M OosterveerRaymund A C Roos
Jun 9, 2009·Seminars in Pediatric Neurology·Donald L Gilbert
Nov 24, 2007·The Journal of Pediatrics·Adrianne R WalkerJames F Bale
Feb 26, 2005·Pediatric Neurology·Judith BarashAbraham Matitiau
Jun 13, 2006·Pediatric Neurology·Alana S GoldenSolomon L Moshé
Jun 6, 2003·Seminars in Pediatric Neurology·Daniel J Bonthius, Bahri Karacay
Jul 12, 2005·Lancet·Jonathan R CarapetisNigel J Wilson
Aug 1, 1997·Rheumatic Diseases Clinics of North America·N A da Silva, B A Pereira
Mar 21, 2017·Developmental Medicine and Child Neurology·Nienke J H van OsUNKNOWN A-T Study Group
Jun 18, 2002·Arquivos de neuro-psiquiatria·Alexandra Prufer de Queiroz Campos AraujoHeber Souza Maia Filho
Oct 18, 2005·Lancet·Kathie Walker, Jo Wilmshurst
Sep 1, 1996·Journal of Child Neurology·M R Pranzatelli
Aug 11, 2007·Journal of Child Neurology·Kaan DemirorenSaadet Demiroren
Dec 24, 2010·Therapeutic Advances in Neurological Disorders·Kathleen G Walker, Jo M Wilmshurst
Mar 29, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Shekeeb S MohammadRussell C Dale
Feb 5, 2002·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Nina BacanerNadov Casuto
Feb 9, 2017·Current Neurology and Neuroscience Reports·Giovanni Cossu, Carlo Colosimo
Jan 26, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·T BakdashF Cardoso
Sep 19, 2003·Journal of Child Neurology·Terence S Edgar
May 24, 2020·Pediatrics International : Official Journal of the Japan Pediatric Society·Meltem DirekCetin Okuyaz
Oct 13, 2019·Pediatric Neurology·Sanem Yilmaz, Jonathan W Mink
Aug 7, 2021·Expert Review of Neurotherapeutics·Antonio L TeixeiraHarvey Singer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.